S65I (p.Ser65Ile) variant of KRAS (GTPase KRas)
S65I (p.Ser65Ile) in KRAS (GTPase KRas) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as likely pathogenic in the context of RASopathy. The available variant effect predictions contribute to a CATVariant prioritization score of 0.67 / 1. The record also includes experimental measurements, published literature, and structural context.
S65I (p.Ser65Ile) variant details
- p.Ser65Ile
- rs1555194026
- ClinGen CA384152083
- cosmic curated COSV55620
- ClinVar RCV000505640
- Likely pathogenic
- RASopathy
- Missense
- Variant Prioritization Score for Impact Estimate 0.674
- ESM-1b 1.00
- AlphaMissense 0.94
- MetaLR 0.43
- MetaSVM -0.13
- CADD 26.60
- PolyPhen-2 0.78
- ClinVar: Likely pathogenic (RASopathy)
- EBI: Likely pathogenic
- UniProt: Likely pathogenic
- Structural context available
- KRAS activity — DMSO (standardized): score 7.32
- Cited in: Noonan Syndrome. (PMID 20301303)
- Cited in: Noonan syndrome: clinical features, diagnosis, and management guidelines. (PMID 20876176)